HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240,775 | +5.9% | 6,303 | 0.0% | 0.01% | +12.5% |
| Q2 2023 | $227,349 | -13.2% | 6,303 | -8.1% | 0.01% | -27.3% |
| Q1 2023 | $262,060 | -32.9% | 6,862 | 0.0% | 0.01% | -73.2% |
| Q4 2022 | $390,448 | +35.6% | 6,862 | -5.7% | 0.04% | +192.9% |
| Q3 2022 | $288,000 | -10.0% | 7,274 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $320,000 | +10.3% | 7,274 | 0.0% | 0.01% | +27.3% |
| Q1 2022 | $290,000 | -0.7% | 7,274 | 0.0% | 0.01% | +10.0% |
| Q4 2021 | $292,000 | -1.4% | 7,274 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $296,000 | -10.3% | 7,274 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $330,000 | +8.9% | 7,274 | 0.0% | 0.01% | +9.1% |
| Q1 2021 | $303,000 | -2.6% | 7,274 | 0.0% | 0.01% | -21.4% |
| Q4 2020 | $311,000 | – | 7,274 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |